BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings

BD Sedi-20 & BD Sedi-40 help improve accuracy and patient outcomes 

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today introduced two new erythrocyte sedimentation rate (ESR) instruments in Europe that standardise analysis for more accurate, timely results and an efficient workflow in comparison to a manual Westergren method. This next generation of BD ESR instruments results in improved patient care in the laboratory or point of care setting.

Erythrocyte sedimentation is a commonly used hematology test to measure inflammation and the presence and severity of disease. “Improved automation and efficiency are key to carrying out analytical tests in a busy laboratory. More and more tests are being conducted each year and reduced healthcare spending puts pressure on laboratory resources,” comments Stephen Church, European Medical Affairs, BD Diagnostics -Preanalytical Systems. 

Manual ESR testing has the potential for errors during the analytical process. The new BD Sedi-20 and BD Sedi-40 combined with BD Seditainer™ tube technology, standardise analysis to improve accuracy. The BD Sedi-40 has an integrated barcode reader and tube mixer. The barcode reader ensures fast, accurate entry of sample identification information. Sample misidentification is one of the many errors which can occur during the preanalytical phase. The integrated mixer ensures consistent and standardised mixing of the sample, which is critical in order to obtain an accurate result. Moving from an open manual process to an automated closed process will improve healthcare worker safety by reducing the risk of exposure to blood-borne pathogens.

With an analysis time of just 30 minutes, a 50% reduction in time to result is achieved compared to the gold standard of one hour with Westergren. BD Sedi-20 can perform 20 tests an hour and the BD Sedi-40 can perform 40 tests an hour. The BD Sedi-40 can be connected to a laboratory information system to enable automatic uploading of results.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BD (Becton, Dickinson and Company). (2019, June 19). BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20131211/BD-Diagnostics-introduces-two-ESR-instruments-to-improve-patient-care-in-point-of-care-settings.aspx.

  • MLA

    BD (Becton, Dickinson and Company). "BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20131211/BD-Diagnostics-introduces-two-ESR-instruments-to-improve-patient-care-in-point-of-care-settings.aspx>.

  • Chicago

    BD (Becton, Dickinson and Company). "BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings". News-Medical. https://www.news-medical.net/news/20131211/BD-Diagnostics-introduces-two-ESR-instruments-to-improve-patient-care-in-point-of-care-settings.aspx. (accessed November 21, 2024).

  • Harvard

    BD (Becton, Dickinson and Company). 2019. BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20131211/BD-Diagnostics-introduces-two-ESR-instruments-to-improve-patient-care-in-point-of-care-settings.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New BD MAX Check-Points CPO assay receives FDA 510(k) clearance